We have one mission, to serve our clients by leveraging our expertise in economics, medical, policy, government affairs, advocacy, and media so that they may fully realize their investment in developing life-changing biopharmaceuticals and devices.Our team of experts will help established and emerging companies enhance their sophistication leading to a greater return on their investment.Our team includes experts have several decades of experience in and with:• Health Economics and Outcomes Research (HEOR)• Phase IV Clinical Trials and Medical Affairs• Regulatory Approval Pathway and Policy• Earned and Social Media• Healthcare Policy (State and Federal)• Lobbying (State and Federal)• Provider and Patient Alliance Development (Including Coalition Building)• Scope of Practice• Employers Biopharmaceutical BenefitsEstablished Content in: • Payment Reform for Established and New Therapies• Drug Pricing, Spending, Affordability and Accesso Rebates Contractingo Reference Pricing, International Price Index and Most Favored Nationo Health Information Technology Assessment – ICER, NICE and IQWiGo Accumulators and Maximizerso Patient Assistance Programso 340B Programo Administrative Burden – Step Therapy and Prior Authorizationo Medication Adherence Policies and Technologies• Generic and Authorized Generic Pricing and Access• Research and Development Payment and Policy• Therapeutic Areas of Focuso Vaccineso Biosimilarso Nutraceuticalso Rare and Ultra Rare Diseaseso Orphan Drugso Cell and Gene Therapies

Lead the healthcare advocacy function of Pfizer US Government Relations (USGR) to ensure:• Management of the Pfizer’s Advocacy Team• The development of a national USGR advocacy platform• Guidance of Advocacy and Professional Relations and Alliance Development Managers• Alignment amongst national and state organizations on priorities • Head USGR adherence legislative outreach (medication synchronization and 90-day fill), including developing legislative language, guiding USGR colleagues, and collaborating with third-party organizations.• Direct USGR collaboration and interaction with science policy team; ensure the development of applicable science and economic policy advocacy platform and material appropriate for USGR.• Lead USGR efforts in identifying internal champions (e.g., medical, trade relations, research colleagues …) to mobilize on the issues externally and ensure third party engagement with national pharmacy and medical organizations, think tanks, and select patient groups and all state advocacy.US State Government Relations and Federal Government Relations• Lead USGR regarding biosimilar strategy, the passage of separate j-codes for biosimilars.• Maintain a portfolio of national and state think tanks and provider and patient organizations; ensure appropriate engagement to advance and garner support for federal and state commercial, policy and legislative priorities through papers, op-eds, hill briefings, etc.• Represent Pfizer at national meetings to discuss and present on science and economic policy and advocacy topics.• Author a monthly published column in Morning Consult on various science and economic policy issues.Therapeutic expertise: Biosimilars, Vaccines, Infectious Diseases, Rare DiseasesPolicy expertise: Pricing, Payment Reform, Affordability, Market Access, Biosimilars, Vaccines

• Developed and engaged medical opinion leaders and provider organizations related to Pfizer’s commercial, health policy and legislative priorities. • Drove policy change using strategic media campaigns, legislation, and medical/economic/policy education.• Shaped a favorable access and reimbursement environment for private and public payers.

• Developed national strategy for the State Government Affairs Division.• Designed Allergan’s Medicaid reimbursement strategy and key health policy positions.• Partnered with patient groups, medical societies, and AFL/CIO state leadership.• Primary contact for the National Health Policy Council regarding the Health Policy Forums.• Advisor to the field-based Directors of State Government Affairs regarding key state legislation.

• Developed and led Diabetes and Metabolism field based medical team responsible for development of opinion leaders, medical and scientific presentations, and implementation of research and scientific protocols.• Science Ambassador - Global R&D Outreach with Legislators, Policy Institutes, and Payers

• Engaged medical opinion leaders and organizations focused on healthcare policy for long-term care, managed markets, and public payers.• Science Ambassador - Global R&D Outreach with Legislators, Policy Institutes, and Payers• Member of Evidence Based Medicine Steering Committee

• Engaged medical opinion leaders and organizations focused on public payer policy issues. • Collaborated with Government Relations to provide medical consultation regarding important health policy and legislative issues impacting and/or restricting patient access.• Member of Evidence Based Medicine Steering Committee

• Responsible for Pain, Allergy, and Immunology therapeutics for the West Region, including development of key opinion leaders, medical organizations, research and medical initiatives, and product defense outreach. • Lead for West Region Medical Council

• First regional Medical Director for Pfizer in the West Region• Collaborated with the other regional Medical Directors in the permanent establishment of the regional Medical Director function

• Led the inclusion of health utilization and outcomes data (trovafloxacin) for the first time in an FDA approved indicated product label. • Led the Infectious Diseases Outcomes Research function